Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-186.53%
operating margin TTM
-145.03%
revenue TTM
846.75 Thousand
revenue per share TTM
0.01$
valuation ratios | |
|---|---|
| pe ratio | -4.69 |
| peg ratio | -0.24 |
| price to book ratio | -3.05 |
| price to sales ratio | 8.47 |
| enterprise value multiple | -6.78 |
| price fair value | -3.05 |
profitability ratios | |
|---|---|
| gross profit margin | 87.25% |
| operating profit margin | -145.03% |
| pretax profit margin | -186.53% |
| net profit margin | -186.53% |
| return on assets | -114.26% |
| return on equity | 77.32% |
| return on capital employed | -145.06% |
liquidity ratios | |
|---|---|
| current ratio | 2.23 |
| quick ratio | 2.19 |
| cash ratio | 1.45 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 70.23 |
| operating cycle | 208.58 |
| days of payables outstanding | 20.91 |
| cash conversion cycle | 187.67 |
| receivables turnover | 2.64 |
| payables turnover | 17.46 |
| inventory turnover | 5.20 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.01 |
| debt equity ratio | -0.01 |
| long term debt to capitalization | -0.01 |
| total debt to capitalization | -0.01 |
| interest coverage | -3.04 |
| cash flow to debt ratio | -82.99 |
cash flow ratios | |
|---|---|
| free cash flow per share | -3.07 |
| cash per share | 1.84 |
| operating cash flow per share | -3.07 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -82.99 |
| short term coverage ratios | -381.10 |
| capital expenditure coverage ratio | -1,876.92 |
Frequently Asked Questions
When was the last time Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) reported earnings?
Phathom Pharmaceuticals, Inc. (PHAT) published its most recent earnings results on 30-10-2025.
What is Phathom Pharmaceuticals, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT)'s trailing twelve months ROE is 77.32%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Phathom Pharmaceuticals, Inc. (PHAT) currently has a ROA of -114.26%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did PHAT's net profit margin stand at?
PHAT reported a profit margin of -186.53% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is PHAT's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.23 in the most recent quarter. The quick ratio stood at 2.19, with a Debt/Eq ratio of -0.01.